Sánchez, D.; Cesarman-Maus, G.; Romero, L.; Sánchez-Verin, R.; Vail, D.; Guadarrama, M.; Pelayo, R.; Sarmiento-Silva, R.E.; Lizano, M.
The NDV-MLS as an Immunotherapeutic Strategy for Breast Cancer: Proof of Concept in Female Companion Dogs with Spontaneous Mammary Cancer. Viruses 2024, 16, 372.
https://doi.org/10.3390/v16030372
AMA Style
Sánchez D, Cesarman-Maus G, Romero L, Sánchez-Verin R, Vail D, Guadarrama M, Pelayo R, Sarmiento-Silva RE, Lizano M.
The NDV-MLS as an Immunotherapeutic Strategy for Breast Cancer: Proof of Concept in Female Companion Dogs with Spontaneous Mammary Cancer. Viruses. 2024; 16(3):372.
https://doi.org/10.3390/v16030372
Chicago/Turabian Style
Sánchez, Diana, Gabriela Cesarman-Maus, Laura Romero, Rogelio Sánchez-Verin, David Vail, Marina Guadarrama, Rosana Pelayo, Rosa Elena Sarmiento-Silva, and Marcela Lizano.
2024. "The NDV-MLS as an Immunotherapeutic Strategy for Breast Cancer: Proof of Concept in Female Companion Dogs with Spontaneous Mammary Cancer" Viruses 16, no. 3: 372.
https://doi.org/10.3390/v16030372
APA Style
Sánchez, D., Cesarman-Maus, G., Romero, L., Sánchez-Verin, R., Vail, D., Guadarrama, M., Pelayo, R., Sarmiento-Silva, R. E., & Lizano, M.
(2024). The NDV-MLS as an Immunotherapeutic Strategy for Breast Cancer: Proof of Concept in Female Companion Dogs with Spontaneous Mammary Cancer. Viruses, 16(3), 372.
https://doi.org/10.3390/v16030372
